AI Article Synopsis

  • Transcriptome quality control is essential in RNA-Seq but challenging without a reference genome for de novo assemblies.
  • A new method called Bellerophon was developed to assess and enhance the quality of these transcriptomes by removing chimeric sequences that result from faulty assemblies.
  • Bellerophon utilizes TransRate for quality assessment, filters lowly expressed contigs using a TPM approach, and employs CD-HIT-EST to eliminate highly identical contigs, successfully removing up to 91.9% of chimeras in test experiments.

Article Abstract

Transcriptome quality control is an important step in RNA-Seq experiments. However, the quality of de novo assembled transcriptomes is difficult to assess, due to the lack of reference genome to compare the assembly to. We developed a method to assess and improve the quality of de novo assembled transcriptomes by focusing on the removal of chimeric sequences. These chimeric sequences can be the result of faulty assembled contigs, merging two transcripts into one. The developed method is incorporated into a pipeline, which we named Bellerophon, that is broadly applicable and easy to use. Bellerophon first uses the quality assessment tool TransRate to indicate the quality, after which it uses a transcripts per million (TPM) filter to remove lowly expressed contigs and CD-HIT-EST to remove highly identical contigs. To validate the quality of this method, we performed three benchmark experiments: (1) a computational creation of chimeras, (2) identification of chimeric contigs in a transcriptome assembly, (3) a simulated RNA-Seq experiment using a known reference transcriptome. Overall, the Bellerophon pipeline was able to remove between 40% and 91.9% of the chimeras in transcriptome assemblies and removed more chimeric than nonchimeric contigs. Thus, the Bellerophon sequence of filtration steps is a broadly applicable solution to improve transcriptome assemblies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787812PMC
http://dx.doi.org/10.1002/ece3.5571DOI Listing

Publication Analysis

Top Keywords

bellerophon pipeline
8
chimeras transcriptome
8
quality novo
8
novo assembled
8
assembled transcriptomes
8
developed method
8
chimeric sequences
8
broadly applicable
8
transcriptome assemblies
8
quality
6

Similar Publications

Accelerated progression of chronic obstructive pulmonary disease (COPD) is associated with increased risks of hospitalization and death. Prognostic insights into mechanisms and markers of progression could facilitate development of disease-modifying therapies. Although individual biomarkers exhibit some predictive value, performance is modest and their univariate nature limits network-level insights.

View Article and Find Full Text PDF
Article Synopsis
  • Transcriptome quality control is essential in RNA-Seq but challenging without a reference genome for de novo assemblies.
  • A new method called Bellerophon was developed to assess and enhance the quality of these transcriptomes by removing chimeric sequences that result from faulty assemblies.
  • Bellerophon utilizes TransRate for quality assessment, filters lowly expressed contigs using a TPM approach, and employs CD-HIT-EST to eliminate highly identical contigs, successfully removing up to 91.9% of chimeras in test experiments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!